Home/ Supplements/ Feverfew/ Feverfew Head Aid 615 mg

Feverfew Head Aid 615 mg

product on market Tablet or Pill Planetary Herbals Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Feverfew Head Aid 615 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Botanical with Nutrients
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
47 mg (5% DV)
Proprietary Blend (Herb/Botanical)
615 mg

Other Ingredients

Dibasic Calcium Phosphate Stearic Acid Silica modified Cellulose Gum Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: 1 tablet three times daily between meals.

Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

Planetary Herbals Feverfew Head Aid unites standardized extracts of feverfew and willow bark with Chinese classics, such as schizonepeta and notopterygium.

Additional Information

Trial size Standardized feverfew complex

Formulated by Michael Tierra L.Ac, O.M.D

The botanicals in Feverfew Head Aid represent a superb blending of modern European science with traditional Chinese herbalism.

PF0447 REV C161-D

Metadata

Product Details

UPC / SKU0 21078 10447 6
DSLD Entry Date2017-08-22
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID77583
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.